Skip to main content

Genmedica, a business case success in India

By 21 de May de 2012November 18th, 2020No Comments
< Back to news

Genmedica, a business case success in India

Farmantra, the consulting company focused on international business development, organizes the conference Internationalization of Life Sciences companies: the India Paradigm. It will take place the coming 7th June at Barcelona Activa. It will analyze the situation of the pharmaceutical industry in Spain and will address the internationalization process and business development key issues at present between Spain and India. Also, it will present business development cases in this Asian country, especially, of the Catalan biotech company Genmedica, providing recommendations to carry out business there.

The conference will count with the participation of Adela Farré, Biocat Director of Communications and External Relations; Luc Martí, Head of Biology at Genmedica Therapeutics; Saurabh Mishra, director of Farmantra, and Sudhanshu Karandikar, member of Farmantra Board of Advisors.

India is one of the first global manufacturers of generics and biosimilars and is the market where big European and American laboratories seek new partners to develop some of their production processes. In December 2010, ACC1Ó published the study Biotechnology in India: Its Policy and Normative Framework, about the legal and institutional framework of the biotechnology sector in India, aimed at Catalan companies interested in entering this market.

Since 2009, Biocat has an agreement of collaboration with the Federation of Asian Biotech Associations (FABA) to promote scientific and commercial relations between the Bioregion of Catalonia and Genome Valley, the main biocluster of India located in the State of Andhra Pradesh.